Diar DeRozan deserved her own highlight reel tonight 🔥 x.com/BleacherReport…

Introducing Multiple Myeloma & Lymphoma Summit faculty, Lindsey Fitzgerald of Huntsman Cancer Institute! Dr. Fitzgerald will present "Frontline treatment of patients with DLBCL." REGISTER: education.binayfoundation.org/content/multip… @MyelomaSLC Harsh Shah #BTFMML #MayEvents #2023Events #CME

Dr Sborov starting off the myeloma lymphoma summit! Beyond Trauma Foundation

Dr. Fitzgerald presenting on management of DLBCL! Beyond Trauma Foundation

Dr Halwani educating us on CTCL! Beyond Trauma Foundation

Dr Boyu Hu discussing management of frontline cHL! Beyond Trauma Foundation Huntsman Cancer Institute

Genetic-subtype guided R-CHOP-X treatment resulted in superior DLBCL outcomes vs R-CHOP in the randomized phase 2 GUIDANCE-01 trial. Great effort exploiting subtype-specific vulnerabilities of DLBCL. Phase 3 trial vs R-CHOP is already ongoing. Cancer Cell cell.com/cancer-cell/fu…

Really pleased to highlight a fascinating study by the incredible Matthew Mei. Using HDAC inhibitors in an attempt to re-sensitise patients to PD1 inhibitors in #Hodgkin lymphoma. #lymsm sciencedirect.com/science/articl…

Ex-college football staffer shared docs with Michigan, showing a Big Ten team had Wolverines' signs apnews.com/article/michig…

Sources to Tom VanHaaren and me: B1G received documents from Michigan that U-M says show Ohio State, Rutgers and Purdue communicated about U-M's signals in 2022. Docs show Purdue, which faced U-M in B1G champ game, got offense signals from Ohio St + D signals from Rutgers, per sources.

RT this if you don't know what an injunction is but it just now became the most important thing in your life.

BET

The road to 1,000 wins has been filled with countless memories and incredible moments. It's great to be a Michigan Wolverine! #GoBlue | #Winningest | mgoblue.com/1000wins

Congratulations to Dr. Victoria Vardell (1st year) and Dr. Kelsey Baron (3rd year) on their poster presentations at #ASH23 ! UofUHeme #lymsm

Who are we University of Utah Health Huntsman Cancer Institute Division of Hematology & Hematologic Malignancies? 30 Clinicians, 5 Physician-scientists, 7 PhDs, 33 APCs, and a large group of support staff.